387 filings
Page 7 of 20
6-K
SCNI
Scinai Immunotherapeutics Ltd
8 Apr 22
Report of Foreign Private Issuer
8:00am
6-K
SCNI
Scinai Immunotherapeutics Ltd
4 Apr 22
Report of Foreign Private Issuer
5:19pm
6-K
SCNI
Scinai Immunotherapeutics Ltd
4 Apr 22
Report of Foreign Private Issuer
7:08am
SC 13D/A
SCNI
Scinai Immunotherapeutics Ltd
11 Jan 22
BiondVax Pharmaceuticals / NACHT MARIUS ownership change
12:47pm
6-K
SCNI
Scinai Immunotherapeutics Ltd
11 Jan 22
Report of Foreign Private Issuer
6:06am
6-K
SCNI
Scinai Immunotherapeutics Ltd
30 Dec 21
Former CFO of GSK’s Global Vaccines Business Mr. Jay Green Joins BiondVax’s Board of Directors
4:15pm
6-K
SCNI
Scinai Immunotherapeutics Ltd
29 Dec 21
Report of Foreign Private Issuer
6:06am
424B5
SCNI
Scinai Immunotherapeutics Ltd
28 Dec 21
Prospectus supplement for primary offering
5:20pm
6-K
SCNI
Scinai Immunotherapeutics Ltd
27 Dec 21
BiondVax Announces Pricing of $9.0 million Follow-on Underwritten Offering of American Depositary Shares
4:15pm
424B5
SCNI
Scinai Immunotherapeutics Ltd
27 Dec 21
Prospectus supplement for primary offering
6:22am
6-K/A
SCNI
Scinai Immunotherapeutics Ltd
27 Dec 21
Current report (foreign) (amended)
6:03am
6-K
SCNI
Scinai Immunotherapeutics Ltd
22 Dec 21
Report of Foreign Private Issuer
4:15pm
6-K
SCNI
Scinai Immunotherapeutics Ltd
13 Dec 21
Report of Foreign Private Issuer
7:34am
6-K
SCNI
Scinai Immunotherapeutics Ltd
2 Dec 21
BiondVax announces Third Quarter 2021 Financial Results and Provides Business Update
4:15pm
6-K
SCNI
Scinai Immunotherapeutics Ltd
24 Nov 21
BiondVax Announces Notice of Annual General Meeting of Shareholders and Provides a Business Update
3:06pm
6-K
SCNI
Scinai Immunotherapeutics Ltd
22 Nov 21
Report of Foreign Private Issuer
6:05am
6-K
SCNI
Scinai Immunotherapeutics Ltd
12 Nov 21
Report of Foreign Private Issuer
8:22am
6-K
SCNI
Scinai Immunotherapeutics Ltd
25 Oct 21
BiondVax advances its growth strategy towards a new pipeline based on innovative VHH antibodies
6:04am
6-K
SCNI
Scinai Immunotherapeutics Ltd
26 Aug 21
BiondVax Announces Second Quarter 2021 Financial Results and Provides Business Update
4:32pm